Cargando…

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

INTRODUCTION: This multicenter phase II study determined the efficacy and safety of new daily oral S-1 and weekly irinotecan (CPT-11) combination schedule in patients with previously untreated advanced or recurrent colorectal cancer. PATIENTS AND METHODS: Patients received first-line chemotherapy co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Yutaka, Tanaka, Takaho, Akagi, Yoshito, Ishibashi, Nobuya, Tsuji, Yoshiaki, Matono, Keiko, Isobe, Makoto, Sueyoshi, Susumu, Kaibara, Atsushi, Shirouzu, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572922/
https://www.ncbi.nlm.nih.gov/pubmed/23439317
http://dx.doi.org/10.4137/CMO.S10769